top of page
Image by Milad Fakurian

Trace In The News

Read about all recent and past news about Trace Biosciences. We are a fast-growing startup, so keep yourself updated on our exciting developments.

stanford medicine.webp

Trace Biosciences sponsors Stanford Symposium & our CEO Connor Barth, Ph.D. speaks about clinical translation and reimbursement

January 2026

5Z3A6629_edited.png

We are IND approved for our first agent! We will now begin expediting preparations for Phase I/II of clinical trials

December 2025

IMG_7190_edited_edited.png

Patent application filed for our latest first-in-class imaging agents, containing composition of matter and methods of use. 

December 2025

Connor at Mayo .jpeg

Trace Biosciences attends and participates in the Mayo Clinic BEAHRS Surgical Innovation Summit

November 2025

Oregon Bio Award.jpg

Trace CEO, Connor Barth, is awarded Bio Entrepreneur of the Year at Oregon Bio 2025

October 2025

Screenshot 2026-01-28 at 11.13_edited.jp

New nerve-specific agent library is published in Biomaterials

February 2025

IMG_2040.JPG

Trace HQ has moved and our new lab space is officially open!

October 2024

WCET.png

Trace Biosciences wins best oncology paper award at WCET 2024

August 2024

arpah.jpg

Trace Biosciences is part of Cancer Moonshot: Precision Surgical Interventions program awarded by ARPA-H

August 2024

resi.jpg

Trace Biosciences is selected to present as an Innovator's Pitch Finalist at RESI JPM 2024.

December 2024

oregon life sciences .png

Trace Biosciences wins Judge's Choice Best Pitch at The Oregon Bio Innovation Showcase.

October 2023

arpah.png

Trace Biosciences is awarded fast-track SBIR funding from the ARPA-H

September 2023

advanced matieral _edited.jpg

Our library generation work is published in Advanced Materials

August 2023

NIH.png

Trace Biosciences is awarded Phase I SBIR funding from the NCI

July 2023

small science _edited.png

Our formulation and preclinical work is published in Small.

July 2023

elevate capital .jpg

Trace Biosciences received pre-seed investment from Elevate Capital Gap Fund

May 2023

ONAMI.png

Trace Biosciences received pre-seed investment from ONAMI at AOBio Finale

May 2023

NINDS.jpg

Trace Biosciences is awarded Phase I SBIR funding from the NINDS

September 2022

NIH_edited.png

Trace Biosciences is awarded Fast-track SBIR funding from the NCI

November 2021

scifounders .png

Trace Biosciences is accepted into SciFounders Fellowship and receives investment

April 2021

STM_edited_edited.png

Our breakthrough library development work is published in Science Translational Medicine

May 2020

Trace Bio Logo White

We provide solutions that help doctors and hospitals make surgery outcomes better for patients. 

People want to live, not just survive. We deliver cutting edge imaging technology that empowers patients and surgeons to improve their outcomes for nerve-injury free surgery. 

FUNDED BY 

ARPA-H Logo
NIH Logo
NSF Logo
Elevate Capital Logo
Oregon State Seal
ONAMI Logo

FEATURED IN

STM Logo
Advanced Materials Logo
Small Logo
Biomaterials Logo
Theranostics Logo

ON TRIAL AT

Information on this website pertains to pre-clinical or clinical-stage medical agents in development that have not been approved by the Food and Drug Administration.

Dartmouth Health
  • LinkedIn

© 2026 by Trace Biosciences. All rights reserved.

bottom of page